Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Erectile dysfunction Stories

2011-07-13 08:00:00

TIRAT CARMEL, Israel, July 13, 2011 /PRNewswire/ -- Initial Results are Encouraging, Spurring Hope for a Treatment Option With a Lower Rate of Complications InSightec Ltd., the global leader in MR-guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that 23 patients with organ confined low risk prostate cancer have already been treated with its ExAblate(R) system in...

2011-07-12 00:00:58

Boston Medical Group, the nation's foremost provider of Men's Sexual Health services, opens a new clinic in Scottsdale, AZ. The Scottsdale location marks the twenty second clinic opening in the United States. Scottsdale, AZ (PRWEB) July 11, 2011 Boston Medical Group, the nation's foremost provider of Men's Sexual Health services, opens a new clinic in Scottsdale, AZ. The Scottsdale location marks the twenty second clinic opening in the United States. The Scottsdale facility offers expert,...

2011-06-30 05:45:00

MOUNTAIN VIEW, Calif., June 30, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of avanafil, its investigational drug for the treatment of erectile dysfunction (ED). The NDA submission follows the successful completion of an extensive phase 3 program for avanafil, which included over 1,350 patients, where avanafil was shown to be well tolerated and effective...

2011-06-24 16:00:00

LA JOLLA, Calif., June 24, 2011 /PRNewswire/ -- Cebix Incorporated announced today that preclinical data for its long-acting form of C-peptide, Ersatta(TM) (CBX129801), demonstrated a half-life of three days as compared to one hour for native C-peptide. Ersatta halted the impairment in nerve conduction velocity, a measure of the rate at which electrical signals travel through the nerves, in an animal model of diabetic peripheral neuropathy. Additionally, clinical data showed that native...

2011-06-23 00:00:31

The Oklahoma law firm of Atkins & Markoff and their team of defective drug lawyers hereby announces that it is offering free and confidential initial consultations for people who believe they are suffering from impotence and sexual dysfunction possibly due to Propecia use for hair loss. More information on whether or not a Propecia lawsuit can be filed may be found by visiting the newly added Propecia resource at http://www.atkinsandmarkoff.com (PRWEB) June 22, 2011 The Oklahoma law...

2011-06-17 05:45:00

MOUNTAIN VIEW, Calif., June 17, 2011 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that the positive results from REVIVE-RP (TA-303), a phase 3 clinical trial evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED),will be presented this afternoon at the 2011 Cancer Survivorship and Sexual Health Symposium in Washington D.C. The meeting is jointly sponsored by the International Society for Sexual Medicine (ISSM)...

2011-06-15 08:45:00

MINNETONKA, Minn., June 15, 2011 /PRNewswire/ -- American Medical Systems® (AMS) (NASDAQ: AMMD), a leading provider of world-class devices and therapies for male and female pelvic health, announced today the commencement of a major global registry of penile prosthetic outcomes. The registry, entitled PROPPER (Prospective Registry of Outcomes with Penile Prosthesis for Erectile Restoration), is led by a team of prominent urologists seeking to better characterize patient...

2011-06-15 06:30:00

CRANBURY, N.J., June 15, 2011 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN), a biopharmaceutical company developing bremelanotide for sexual dysfunction indications, announced presentation and publication of a report on validation of a scale for subjective male sexual arousal. The underlying study was supported by grants from Palatin. Michael A. Perelman, Ph.D., of the New York Presbyterian Hospital and the Weill Medical College of Cornell University, presented the poster on...

2011-06-06 14:55:41

Low testosterone levels and symptoms of male sexual dysfunction due to obesity may be reversible with weight loss after bariatric surgery, a new study finds. The results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston. "Morbidly obese men have a high prevalence of hypotestosteronenemia, or low testosterone, and of sexual dysfunction," said study co-author Jean-Paul Thissen, MD, PhD, a professor at the University of Louvain in Brussels. "It is reassuring...

2011-06-02 13:37:11

A new study published in the journal Clinical Cardiology reveals that in men with chronic heart failure, cardiac resynchronization therapy (CRT) improves patients' libido, erectile dysfunction, and sexual performance. Chronic heart failure (HF) is a common, complex clinical syndrome characterized by fatigue and exercise intolerance. HF patients experience decreased libido and erectile dysfunction (ED). CRT, which is a type of pacemaker that paces the right and left ventricle, is used to treat...